Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MLD10 for Migraine Prevention
NCT02322333Phase 3Completed
- Sponsor
- Pharmalyte Solutions
- Start
- Mar 2015
- Primary completion
- Jun 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of magnesium in migraine, sponsored by Pharmalyte Solutions. Started Mar 2015; status: completed.
02
Drugs
magnesium
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02322333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02322333.